Formulation: A 1 mg/ml solution in methanol

• BAY-1470

Formulation: A crystalline solid

Purity: ≥98%

• MPV 785

Formulation: A 1 mg/ml solution in methanol

Formulation: A 1 mg/ml solution in methanol

• p-hydroxy Xylazine
• para-hydroxy Xylazine

Formulation: A solid

Purity: ≥99% (deuterated forms d₁-d₆)

Formulation: A 1 mg/ml solution in methanol

• MPV 785

Formulation: A crystalline solid

Purity: ≥98%

• BAY-1470

Formulation: A crystalline solid

Purity: ≥98%

• (+)-Etomidate
• d-Etomidate
• (R)-Etomidate
• R 16659

Formulation: A 1 mg/ml solution in methanol

• (+)-Etomidate
• d-Etomidate
• (R)-Etomidate
• R 16659

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₆)

• p-hydroxy Xylazine-d₆
• para-hydroxy Xylazine-d₆

Formulation: A 1 mg/ml solution in methanol

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

• MPV 785-d₃

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥98%

• (+)-Isopropoxate
• (R)-Isopropoxate

Formulation: A crystalline solid

Purity: ≥97%

Formulation: A 10 mg/ml solution in acetonitrile

Purity: ≥98%

• (+)-R 7464
• (R)-Propoxate

Formulation: A solid

Purity: ≥98%

• R-28141

Formulation: A 100 μg/ml solution in methanol

• p-hydroxy Xylazine-d₆
• para-hydroxy Xylazine-d₆

Formulation: A crystalline solid

Purity: ≥98%

• MPV 253AII

Formulation: A solid

• 2,6-Dimethylaniline-d₆
• 2,6-DMA-d₆

Formulation: A crystalline solid

Purity: ≥98%

• ST 155

Formulation: A solid

Purity: ≥95%

• 2,6-Dimethylaniline
• 2,6-DMA

Formulation: A crystalline solid

Purity: ≥98%

• DS 103-282

Formulation: A crystalline solid

Purity: ≥98%

• 2,6-Dimethylphenylthiourea
• NSC 202179

Formulation: A crystalline solid

Purity: ≥99% deuterated forms (d₁-d₅)

• (+)-Etomidate-d₅
• d-Etomidate-d₅
• (R)-Etomidate-d₅